Figure 1:

Major pulmonary complication event rates (unadjusted) in matched cohort of patients undergoing noncardiac inpatient surgery

Patients receiving sugammadex were matched to patients receiving neostigmine across twelve hospitals using exact match criteria of institution, sex, age, comorbidities, obesity, surgical procedure type, and neuromuscular blockade agent. The composite pulmonary complication primary outcome included pneumonia, respiratory failure, and other major complications.